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Abstract
Aims We aimed to determine the patient and screening-level factors that are associated with non-attendance in the Irish 
National Diabetic Retinal screening programme (Diabetic RetinaScreen). To accomplish this, we modelled a selection of 
predictors derived from the historical screening records of patients with diabetes.
Methods In this cohort study, appointment data from the national diabetic retinopathy screening programme (RetinaScreen) 
were extracted and augmented using publicly available meteorological and geospatial data. A total of 653,969 appointments 
from 158,655 patients were included for analysis. Mixed-effects models (univariable and multivariable) were used to estimate 
the influence of several variables on non-attendance to screening appointments.
Results All variables considered for analysis were statistically significant. Variables of note, with meaningful effect, were 
age (OR: 1.23 per decade away from 70; 95% CI: [1.22–1.24]), type 2 diabetes (OR: 1.10; 95% CI: [1.06–1.14]) and socio-
economic deprivation (OR: 1.12; 95% CI: [1.09–1.16]). A majority (52%) of missed appointments were from patients who 
had missed three or more appointments.
Conclusions This study is the first to outline factors that are associated with non-attendance within the Irish national diabetic 
retinopathy screening service. In particular, when corrected for age and other factors, patients with type 2 diabetes had higher 
rates of non-attendance. Additionally, this is the first study of any diabetic screening programme to demonstrate that weather 
may influence attendance. This research provides unique insight to guide the implementation of an optimal and cost-effective 
intervention strategy to improve attendance.
Keywords Diabetic retinopathy · Screening · Public health · Socio-economic issues
Introduction
Diabetic retinopathy is a leading cause of vision loss in 
working-aged and elderly people globally [1]. Many coun-
tries have introduced national screening programmes to 
facilitate the early detection of diabetes-related eye disease 
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[1–3]. While these programmes have proven to be successful 
in preventing blindness, non-attendance remains an issue.
In Ireland, Diabetic RetinaScreen is a government-funded 
national screening programme that aims to reduce diabetes-
related sight loss, namely from diabetic retinopathy (DR) or 
diabetic maculopathy. RetinaScreen began in February 2013 
and provides annual call–recall screening to persons with 
diabetes mellitus aged 12 years and over. It is implemented 
and managed by the National Screening Service (NSS) 
which is a part of the Health Service Executive (HSE) and 
is the first non-cancer population to undergo screening by 
the NSS. In 2019, there were 171,557 people known to have 
diabetes in Ireland who were eligible to be on the RetinaS-
creen register. A total of 158,690 people have been invited 
to attend screening appointments since the inception of the 
programme [4]. By 2019, there were 147,965 patients who 
had consented to take part in the programme, with 10,725 
(7%) having opted out or been removed from the registry. 
Non-attendance is an important factor to consider in a DR 
screening programme because it has been associated with 
ultimately higher costs and worse vision outcomes in dia-
betes patients [5–9].
Previous studies of screening programmes in other coun-
tries have shown that age, diabetes type, and driving time 
to the screening location were associated with non-attend-
ance, but with conflicting results depending on the popula-
tion and study design [1, 5, 10]. The rate of non-attendance 
and reasons associated with non-attendance has yet to be 
investigated in Ireland’s RetinaScreen programme, and this 
is the main idea of this report. Understanding the causes of 
non-attendance in RetinaScreen could lay the foundation for 
determining which population subgroups should be targeted 
for interventions, such as improved communications and 
alternative screening locations and/or appointment times.
The aim of this study was therefore to determine the 
patient and screening-level factors that are associated with 
non-attendance in the Irish national diabetic retinopathy 
screening programme. To accomplish this, we modelled a 
selection of predictors derived from the historical screening 
records of patients with diabetes. Some of these predictors, 
such as temperature, are novel and have not been included in 




Patient’s data were extracted from the Diabetic RetinaS-
creen database used to store details on screening appoint-
ments between March 2013 and March 2020. These records 
included details on patients’ sex, date of birth, address, type 
of diabetes (type 1 diabetes mellitus; T1DM or type 2 dia-
betes mellitus; T2DM) as well as details of their screening 
time, date, and clinic location. The screening programme 
uses two-field (macula centred and disc centred) 45-degree 
images captured on quality assured and standardized cam-
eras [4]. All study participants provided informed written 
consent prior to the study as a part of the screening pro-
gramme consent form and this study followed the tenets of 
the Declaration of Helsinki.
Risk factors
Risk factors used for the models in the current study were 
as follows: sex, age, diabetes type, socio-economic sta-
tus (SES), driving time to the clinic, years since the first 
appointment, previous non-attendance, ambient temperature 
(binarized above and below freezing or 0 ℃), and a clinic 
location at an optometric practice. Based on the distribution 
of non-attendance by age, we determined that age was best 
represented as decades away from a reference of 70 years 
old.
Socio-economic data were obtained from the 2016 Pobal 
HP Deprivation Index. It is a combined score of demo-
graphic profile, social class composition, and labour market 
situation for each Electoral Division (ED) (smallest area of 
analysis currently available for all Ireland). Weather infor-
mation was obtained from historical data from the Irish 
Meteorological Service and contains information on rainfall, 
temperature and barometric pressure at an hourly resolution 
from weather towers around the country. The data from the 
tower nearest the patient at the time of their appointment 
were included.
Driving times for each appointment were calculated using 
the Open Source Routing Machine (OSRM) which uses road 
network mapping from OpenStreetMap. It calculates the dis-
tance (in metres) and time (in seconds) between two geo-
graphical locations, taking into account the average speed 
and speed limits of the roads on the journey. Journey times 
were calculated from the centroid of an ED to the address of 
the clinic location. Patients that did not have an ED in their 
file were excluded from the study.
Data analysis
The predictors were modelled univariably against attend-
ance using a mixed-effects logistic regression model. The 
predictors were included as fixed effects, and patients were 
modelled as random effects. Alternative mixed-effects mod-
els were tested that included a clinic-level random effect and 
a nested clinic-patient random effect but were not chosen 
based on Akaike information criterion (AIC) values.
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All analyses were carried out in R (version 4.0.1; R Foun-
dation for Statistical Computing, Vienna, Austria). A p-value 
of 0.001 or less was considered statistically significant.
Results
A total of 653,969 appointments from 158,655 patients over 
seven years were included in the analysis. Some patients 
(1328) were excluded due to missing ED data. An addi-
tional 35 patients were excluded due to being labelled as 
having both T1DM and T2DM. Table 1 depicts the charac-
teristics of the study population. There were 16,988 Type 
1 diabetic (T1DM) patients and 141,667 Type 2 diabetic 
(T2DM) patients. Median (IQR) age was 65.2 (54.6–73.8) 
years. The overall non-attendance rate for all appointments 
was 18.5%; and for individual patients, it was 33.9% (i.e., 
the proportion of patients with at least one missed appoint-
ment). Figure 1 shows the distribution of non-attendance by 
age (left panel). As the relationship is nonlinear, including 
it in a logistic regression model as a continuous variable 
would lead to a poor estimation of its influence. We therefore 
used decades from 70 as a predictor (Fig. 1, right panel), 
which more closely approximates a linear relationship with 
non-attendance.
Table 2 shows the results of the univariable analysis. In 
these models, female sex, age further away from 70, T1DM, 
low SES, increased driving time to clinic, increased years 
since the first appointment, previous non-attendance, freez-
ing temperatures, and clinic appointments at optometrists 
were associated with a significantly increased risk of non-
attendance. Taking age as an example, this can be interpreted 
as the risk of non-attendance increasing by 24% for each 
decade the patient is older or younger than 70 years old. 
For a driving time, a patient with a 60 min commute to the 
screening clinic is 1.013 = 1.03 or 3% more likely to miss 
an appointment than someone who has a 30 min commute. 
Table 3 shows the results of the multivariable logistic regres-
sion model. In this model, all of the predictors that were sig-
nificant in the univariate model were also significant, and the 
associated risk of non-attendance was in the same direction, 
except for diabetes type. This can be explained by a younger 
Table 1  Characteristics of the 
study population
n = 158,655
Age (yrs; median [IQR]) 65.2 (54.6 to 73.8)
Sex (% Female) 40.2%
Driving time to screening clinic (mins; median [IQR]) 14.6 (7.8 to 24.6)
Diabetes Type (% Type 1) 10.7%
Pobal HP Index (deprivation score; median [IQR])  − 5.8 (− 10.7 to -0.4)
At least one missed appointment (% Yes) 37.0%
Years in screening programme (yrs; median [IQR]) 3.3 (1.2 to 4.6)
Repeated non-attendance
Percentage of study population that missed three or more appointments (%) 9.6%
Percentage of all missed appointments by patients who missed three or more 
appointments
52.8%
Fig. 1  Non-attendance rate by age (left) and non-attendance rate by rate absolute number of years from 70 (right). The blue and red points rep-
resent data from those under and over 70 years old, respectively. For the purposes of illustration, data were censored for those younger than 25
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population in the T1DM cohort compared to T2DM. As age 
has a larger effect on non-attendance compared to diabetes 
type, the effect reverses when this is corrected for.
Discussion
This study is the first to examine the factors associated 
with non-attendance within the Diabetic RetinaScreen 
Programme. We have shown that female sex, age fur-
ther away from 70 years, T2DM, low SES, longer driv-
ing time to the screening clinic, increase in years since 
the first appointment, previous non-attendance, and a 
screening appointment located at an optometry practice 
were all associated with a significantly increased risk of 
non-attendance. Additionally, this is the first study of any 
diabetic screening programme to include a novel possible 
predictor, namely local hourly temperatures. Moreover, a 
majority of missed appointments (52%) were from patients 
who had missed three or more appointments, indicating 
that there may be a subgroup of patients who are unable 
or unwilling to interact with the screening service. Sum-
mary statistics on this subgroup can be found in the Sup-
plementary Materials.
Screening programmes
Despite a decrease in DR in populations with improved 
diabetes control, the crude global prevalence of diabetes-
related visual impairment and blindness has continued to 
increase since the 1980s. A meta-analysis of 35 studies 
estimated that the global prevalence of DR in patients with 
diabetes was around 34.6% [11]. Screening programmes are, 
therefore, paramount to mitigating the personal and finan-
cial impacts of DR. The benefits of screening for DR are 
already well known [12, 13]. Visual impairment due to dia-
betes is lower in countries that have screening programmes 
[12]. Programmes in countries like England and Wales have 
reported retinopathy rates of 21% and 30.5%, respectively 
[14, 15]. While there are no national studies reporting the 
incidence of DR in Ireland, the GUIDANCE study reported 
a microvascular complication rate of 26.3% among the Irish 
participants [16]. Countries that screen for DR also benefit 
financially, spending 7–20 times less than the cost of sup-
porting those diabetes patients if they became blind [12]. 
[17] Although the implementation of screening programmes 
can be cost-effective, national schemes are less common in 
Table 2  Results from univariable models
Predictor Odds ratio Confidence interval p
Sex [Male] 0.92 0.90–0.94  < 0.001
Age [Decades from 70] 1.24 1.22–1.25  < 0.001
Diabetes Type [T2DM] 0.72 0.70–0.75  < 0.001
Driving Time [per 
10 min]
1.01 1.00–1.02  < 0.001
Years Since First 
Appointment
1.06 1.06–1.07  < 0.001
Previous non-attendance 
[Yes]
1.50 1.47–1.54  < 0.001
Temperature [Freezing] 1.57 1.45–1.70  < 0.001
Opticians [Yes] 1.55 1.46–1.64  < 0.001
Pobal HP Index Quintiles 
(reference group is Q3)
– – –
Q1 (most deprived) 1.12 1.08–1.16  < 0.001
Q2 1.03 0.99–1.07 0.896
Q4 1.01 0.98–1.05 0.485
Q5 (most affluent) 0.94 0.91–0.97  < 0.001
Table 3  Results from 
multivariable model
Predictor Odds ratios Confidence interval p
(Intercept) 0.07 0.07–0.07  < 0.001
Sex [Male] 0.94 0.92—0.96  < 0.001
Age [Decades from 70] 1.23 1.22—1.24  < 0.001
Diabetes Type [T2DM] 1.10 1.06—1.14  < 0.001
Driving Time [per 10 min] 1.01 1.00—1.02  < 0.001
Years Since First Appointment 1.02 1.01—1.02  < 0.001
Previous non-attendance [Yes] 1.52 1.48—1.56  < 0.001
Temperature [Freezing] 1.68 1.55—1.81  < 0.001
Opticians [Yes] 1.66 1.57—1.75  < 0.001
Pobal HP Index Quintiles (reference 
group is Q3)
– – –
Q1 (most deprived) 1.12 1.09—1.16  < 0.001
Q2 1.03 1.00—1.07 0.088
Q4 1.00 0.97—1.04 0.913
Q5 (most affluent) 0.91 0.88—0.94  < 0.001
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low and middle-income countries, likely due to the initial 
cost of setting up such programmes.
In 2016, DR was no longer the leading cause of certi-
fiable blindness in the working-age group in England and 
Wales thanks to the success of their national DR screening 
programme, with an uptake of 83% [2]. Diabetic RetinaS-
creen was established in 2013 and sought to replicate the 
success of other screening models such as the UK. How-
ever, a recent study found that one-third of patients who 
were eligible to register had not done so [18]. In addition to 
improving patient uptake, mitigation of non-attendance for 
those who are already part of the programme will minimize 
both costs and poor visual outcomes for diabetes patients. 
It is important to note that a non-attendance rate of 20% 
reduces the cost-effectiveness of a programme by ~ 10%. 
[19, 20] The deeper understanding of the specific factors 
leading patients to miss appointments that were found in 
this study could yield a more targeted and efficient interven-
tion approach. This model has been deployed effectively in 
an Irish context already, and we will look to expand on an 
international basis. [18, 21]
Age and non‑attendance
In the univariable analysis, patients with T1DM seemed to 
have higher non-attendance rates but, once corrected for age 
and other variables in the multivariable model, this effect 
was reversed. This is likely due to younger people, who 
have higher rates of non-attendance in general, making up 
a higher proportion of the T1DM population. Figure 1 (left 
panel) depicts a bimodal distribution of non-attendance rates 
by age, showing that it is the youngest and the oldest popu-
lations that are more likely to miss appointments. A Lon-
don-based study found a similar U-shaped non-attendance 
rate with the youngest and oldest populations missing more 
appointments [22]. Many studies, however, only reported 
younger age being associated with higher non-attendance 
rates [5]. Two studies from south-east London and Tayside, 
Scotland, respectively, found that non-attendance rates were 
higher in younger patients [23, 24]. A third study in Ire-
land also found that younger age was associated with higher 
non-attendance, however, the sample size was small and the 
methodology of univariable logistic regression makes it dif-
ficult to draw strong conclusions [25]. In all of these studies, 
the relationship between age and attendance is either treated 
as linear or stratified into age groups. We suggest that due 
to the underlying bimodal (U-shaped) relationship between 
non-attendance and age, including age in a model in these 
ways skews the observed effect depending on the underly-
ing population being studied. In these examples, a popula-
tion whose age is mostly under 70 would show younger age 
being associated with increased non-attendance. In contrast, 
a study looking at the screening uptake among T2DMs in 
Germany between 2004 and 2013 found that it was older 
patients and those with disabilities who had lower rates of 
screening. The youngest age group in this study was 50–69. 
In this instance, the lack of data on younger patients skewed 
the direction of the observed effect towards older patients 
[26]. In our analysis, we included a transformed age vari-
able to correct for the U-shaped relationship between non-
attendance and age (Fig. 1).
SES and non‑attendance
In the current study, we found an association between socio-
economic deprivation and higher rates of non-attendance. 
The Pobal HP Index is a combined summary measure of 
various subscores based on socio-economic factors of peo-
ple residing in a geographical area. We found that when 
compared to a reference group (the third/middle quintile), 
the most deprived quintile had around 12% higher non-
attendance rates. The most affluent quintile conversely had 
a 9% lower non-attendance rate. These findings are echoed 
in much of the literature. When comparing the first and fifth 
quintiles only, we found that the first quintile had a 21% 
higher non-attendance rate. A review on non-attendance 
within DR screening found that socio-economic depriva-
tion was associated with higher non-attendance rates in all 
studies that reported it [10]. In London, one study found a 
difference in uptake by SES but this was not reflected in 
any difference in sight-threatening DR. [22] Another study 
in Gloucestershire similarly found that uptake was lower 
in socioeconomically deprived populations but unlike the 
London study, sight-threatening DR was also associated 
with SES [27]. In the aforementioned Tayside study, those 
in the most deprived quintile were 2.3 times more likely to 
miss a screening appointment compared to those in the most 
affluent quintile [24]. In south east London, attendance rates 
were significantly lower in patients residing in areas with 
the highest levels of deprivation. [23] In a qualitative study 
looking at the influence of primary care practices on the 
uptake in DR screening, deprivation was a factor listed as 
a barrier to uptake [28]. The negative relationship between 
socio-economic deprivation and health is well-documented 
and not limited to diabetes. It is mainly driven by a com-
bination of material, psychosocial and behavioural factors 
that lead to higher rates of morbidity in socioeconomically 
deprived groups [29]. Given the high rates of private health 
cover in Ireland (46%),  we had estimated that there may 
have been a bimodal non-attendance peak for screening with 
the least affluent not attending for the above reasons but also 
with the most affluent, as they may choose to attend a private 
practitioner over the free state-funded scheme [30]. Indeed 
many patients were attending DR screening privately before 
the introduction of the national programme and have contin-
ued to do so. However, the predicted bimodal distribution 
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of non-attendance does not appear to be the case in our dia-
betic population. Once registered with the national screening 
service, the most affluent quintile missed less appointments 
when compared to more deprived quintiles.
Travel time and non‑attendance
We found a small increase in non-attendance with an 
increase in driving time to the screening clinic (OR: 1.01 
per 10 min). It is possible that there is a difference between 
urban and rural settings where public transport is relied on 
more heavily. An Irish study looking at attendance at treat-
ment centres after referral from the national DR screening 
programme found that people living over 60 km away were 
less likely to attend [31]. The above-mentioned review by 
Kashim et al. noted conflicting findings on whether distance 
to the clinic was associated with non-attendance [10]. In 
the Tayside study, travel time was not associated with non-
attendance but in a study by Lindenmeyer and colleagues in 
England, it was [24, 28]. It is likely that the effect of travel 
time on attendance depends greatly on the demographics of 
the underlying population and the availability of different 
types of transport. A secondary analysis of our data showed 
a slightly higher rate of non-attendance for patients living 
outside of the capital city Dublin compared to those living 
in Dublin (18.9% non-attendance and 17.3% non-attendance, 
respectively).
Non‑attendance and poor outcomes
Non-attendance to screening appointments is associated 
with worse visual outcomes for patients with diabetes. 
[6–8] If patients are not screened, it increases the likeli-
hood that early retinal lesions will not be detected. A study 
from Iceland looked at past screening attendance rates of 
people registered on their national blindness registry. Those 
registered as blind had a worse attendance record hinting at 
an association between non-attendance and vision impair-
ment. [6] One study found that the patient attendance rates 
to ophthalmic clinics were lower among those who were 
registered as partially sighted or blind [7]. The situation is 
more complex than simply attending or not attending screen-
ing appointments and there are many possible confounding 
factors at play. Patients who miss appointments are also the 
ones that tend to have poorer overall health. A systematic 
review listed myriad poor health outcomes associated with 
non-attendance, including microvascular (retinopathy and 
neuropathy) and macrovascular (coronary artery disease and 
peripheral vascular disease) complications [5]. One study 
looked at the change in DR in three London boroughs and 
found that patients who missed screening for one and two 
years were more likely (OR: 3.4 and 10.8, respectively) to 
have referable retinopathy [8]. A later study from the same 
group found a lower incidence of sight-threatening DR from 
patients with mild nonproliferative retinopathy or no retin-
opathy at their first visit [32]. They argued that patients at 
low risk may be suited for less frequent (for example, bien-
nial) screenings.
Interventions
A systematic review of the effectiveness of interventions to 
increase uptake in DR screening programmes found that all 
but one study in 48 showed an increase in attendance within 
the intervention group [33]. Another review concluded that 
essentially any intervention targeting patients, providers, or 
the health care system was associated with a meaningful 
increase in DR screening compared to usual care [34]. In 
fact, there was no difference between DR screening specific 
interventions and a general quality improvement of diabetes 
care strategy [34]. A study of uptake in DR screening found 
that integrating the screening with other care, such as rou-
tine diabetes care or a seasonal flu vaccine, also increased 
attendance [28].
A previous study in Ireland found that one of the main 
barriers to receiving adequate screening was a lack of knowl-
edge regarding the need for ocular examination and that a 
previous physician recommendation about the necessity of 
a regular eye examination improved attendance [35]. Others 
found that improving patient and clinician awareness of DR 
screening was effective [33]. The Diabetic RetinaScreeen 
programme has evolved the information and communication 
approaches over the six rounds of screening to improve this, 
and uptake rates have generally improved. [4]
In the current study, we found that non-attendance was 
more frequent when screenings took place at optometric 
practices. This effect was present for both chain and inde-
pendent optometrists. This could be an issue with the per-
ception of the role of optometrists. It is possible that patients 
associate optometrists with visual complaints, and if they 
do not have visual symptoms from their diabetes, they do 
not see the need for an optometrist. Conveying the impor-
tance of DR-specific ocular examinations is essential, and 
optometrists in Ireland play a role for one of the contracted 
providers for the Diabetic RetinaScreen programme, in par-
ticular in locations outside Dublin. In addition, optometrists 
engage patients about their visual health and can act as a 
valuable reinforcer of the need for regular attendance at Dia-
betic RetinaScreen.
A funded study in Ireland, soon to be underway, aims 
to improve uptake in the national DR screening service by 
introducing provider and patient-level interventions; pro-
vider interventions in the form of training, audit, feedback, 
and reimbursement and patient interventions in the form of 
a GP-endorsed reminder, an information leaflet and a phone/
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letter reminder [36]. It’s likely that this will increase uptake 
but to what degree remains to be seen.
Lastly, it is important to consider inter-individual vari-
ation in reasons for non-attendance. One qualitative study 
found differences in attitudes and motivational factors in 
screening attendance between younger adults and older 
adults. Additionally, in the current study, the number of 
years in the programme was associated with an increase in 
non-attendance. This could mean that patients who have 
many appointments with no visual deterioration place less 
importance on screening. These patients may be candidates 
for a reminder of the importance of screening, even after 
years of attendance. A successful and cost-effective inter-
vention needs to be tailored towards its intended patient 
population and not have a one-size-fits-all approach [37].
Strengths and limitations
The main limitation of this study was the lack of available 
information on HbA1C values. Other studies have high-
lighted the association between high non-attendance rates 
and poor glycaemic control, and it would have been of 
interest to replicate those findings [5]. Although there is an 
association between non-attendance and poorer outcomes 
(discussed below) without associated HbA1c values, we 
cannot make any associations between non-attendance and 
glycaemic control. There was also no visual acuity infor-
mation in this dataset. A comparison of visual outcomes 
with attendance would have been useful and is being incor-
porated into the Optomize™ programme which is the core 
Electronic Medical Record of Diabetic RetinaScreen. One 
major strength of this study is the large and diverse sam-
ple size. As a national database, the patients included were 
from all over Ireland and represented a diverse range of 
demographic profiles. Another strength of this study was 
using a more statistically sound approach of a mixed-effects 
model with a transformation of age. Finally, by linking the 
patients’ appointments with historical weather data, we were 
able to demonstrate a relationship between non-attendance 
and below-zero (freezing) temperatures, likely due to the 
presence of ice on the roads, which has not previously been 
shown. In this study, only 0.8% of the total appointments 
were on days where the temperature was below freezing. 
However, we believe this may be especially relevant to 
consider programmes implemented in other countries with 
colder climates.
This study outlines factors that are associated with non-
attendance within the Irish national diabetic retinopathy 
screening service. Some of the factors listed give insight 
into which population subgroups may benefit from a targeted 
intervention.
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